RATIONALE: Grass carp is a commonly consumed fish species in Hong Kong and Southern China. We investigated the utility of grass carp allergens for diagnosing IgE-mediated fish allergy in Chinese children. METHODS: IgE reactivity against parvalbumin, enolase and aldolase of grass carp were measured by enzyme-linked immunosorbent assay in 76 pediatrics subjects with clinical history of IgE-mediated fish allergy. IgE titers against these grass carp allergens were compared with IgE reactivity to cod extract and recombinant cod parvalbumin rGad c 1 as measured by ImmunoCAP, which is the conventional surrogate for fish allergy diagnosis. RESULTS: Grass carp parvalbumin was found to be the dominant allergen in our study population where IgE reactivity to this allergen was observed in over 80% of our subjects. In contrast, sensitization to enolase and aldolase were only observed in less than 20% of subjects and the IgE reactivity was generally low. IgE reactivity to grass carp parvalbumin was significantly higher than recombinant cod extract or cod parvalbumin rGad c 1. The former allergen demonstrated superior diagnostic sensitivity for fish allergy at the cut-off of 0.35 kU A /L. CONCLUSIONS: Grass carp parvalbumin is a better tool for fish allergy diagnosis in our population when compared to conventional cod extract or cod parvalbumin. RATIONALE: Increasing number of wheat allergic children has been observed in Thailand. The outbreak of immediate type wheat allergy caused by a hydrolyzed wheat protein (HWP) facial soap has been described in Japan. This study aims to assess factors associated with the development of wheat allergy in children include the use of HWP containing baby products. METHODS: Children under 5 years of age with a history of IgE-mediated wheat allergy and age-matched healthy control were enrolled. The questionnaire was used investigate the association between wheat allergy, demographic and environmental factors. RESULTS: Thirty-eight wheat allergic patients and 38 healthy children were enrolled. The mean age was 2.86 years with mean age of onset 7.8 months. Most of them (94.3%) developed their symptoms at the first time of wheat ingestion. The absolute breastfeeding duration, family income, cesarean section rate were significantly higher among cases (P50.047, 0.0012, 0.015, respectively). There was no significant difference between the onset of wheat introduction, the average amount of maternal wheat consumption during pregnancy or breastfeeding and family history of atopy. History of exposure to HWP product was higher in wheat allergic patients compared to controls (52.6% VS 42.1%). Previously used HWP/ oat products were found in 27 (71.1%) of wheat allergy group and 16 (42.1%) of control group. (P50.03, aOR 3.01; 95%CI 1.12-8.14) The median level of sIgE to wheat was 2.8 kUA/l (IQR 1.15-35.6). CONCLUSIONS: HWP/oat products were associated with an increased risk of wheat allergy. It might explain by early cutaneous sensitization from these products. 1 Odense University Hospital, Odense, Denmark, 2 Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark. RATIONALE: Diagnosis of peanut allergy is based on case history, serology measurements and confirmation by oral food challenge. The majority of patients with peanut allergy have elevated IgE towards Ara h2, thus being the superior serological marker for clinical peanut allergy. Few have, however, absent or very low titers of IgE towards Ara h2 nor any other known peanut specific protein (Ara h1, Ara h3, Ara h8, or Ara h9) which could explain their clinical reactivity. We are aiming to describe IgE to a new available peanut component (Ara h6) in relation to clinical reactivity. METHODS: Samples from 134 challenge-positive and 25 negative peanut patients aged 1-26 years, previously analyzed with ImmunoCap (Thermofisher) for specific IgE to peanut and to known peanut components were reanalyzed for Ara h6. IgE levels were correlated and diagnostic values generated using RUC curve analyses. RESULTS: We found high concordance between Ara h6 and Ara h2 (r s 50.93). Diagnostic values for Ara h6 were better than for Ara h2: AUC was 0.95 vs. 0.90 and sens/spec. 88.0/83.3 vs 87.3/66.7. Ara h6 were able to explain clinical reactivity in 9/17 patients without detectable levels of IgE to Ara h2. Further, patients tolerant to peanut but with IgE to Ara h2 had no detectable IgE to Ara h6. Combining the diagnostic capacity of Ara h2 and Ara h6 increased the overall sensitivity to 96.2%. CONCLUSIONS: Measurement of Ara h6 adds additional information to the serological profile of peanut allergic patients, and increases the diagnostic accuracy in patients suspected of peanut allergy. 
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